Cervical Cancer Clinical Trial
Official title:
The Effect of Nursing Interventions on Women's Cervical Cancer Risk for Beliefs / Attitudes and Attendance to Screening Programme; Study Protocol for a Randomized Controlled Trial
In order to evaluate the effectiveness of nursing interventions aimed at the early detection of cervical cancer, health belief and participation in the screening of women aged 40-55 at risk for the purpose of cervical cancer, One-way blind pre-test and post-test randomized controlled trial.
Cervical cancer is the 4th most common cancer type in the world, among women, in all age
groups. Cervical cancer is a high-risk disease, and every two minutes, a woman loses her life
due to cervical cancer. In Turkey, among the most common cancers among all age groups among
women, 9th is the 5th among the most common cancers in the 25-49 age group. Cervix cancer is
a type of cancer that can be prevented and treated at an early stage. Because cervical cancer
has a long preclinical period, it has an early diagnosis possibility. For this reason,
cervical cancer is one of the cancers recommended by World Health Organization (WHO)
screening programs. In countries where regular screenings have been conducted, death rates
from cervical cancer have decreased. In developing countries, high incidence and mortality
continue due to the inadequacy of screening programs.
The first step in the early diagnosis of cervical cancer is usually the result of an abnormal
Pap smear test. The Pap smear test is an ideal cytologic screening test used for screening
because it can identify early onset of a cellular change that may be a starting point for
cervical cancer and is cost effective. The number of women who have had the Pap smear test,
which is so important in early diagnosis, is not at a level all over the world and in our
country. In developed countries, cervical cancer screening rates are over 60%, while in
underdeveloped and developing countries this rate is below 20%. In our country, the rate of
not having any pap smear test over the age of 15 years is 77.9%.
Studies have shown that when women with cervical cancer are diagnosed early, their life span
is prolonged and their chances of survival increase. Early diagnosis of cervical cancer is a
simple, feasible and economical method. Women's lack of knowledge, worries about negative
test results, and their reasons for not having a Pap smear test are among the reasons. Along
with being semi-empirical studies in our country, most are based solely on education and do
not involve a risk group approach. In addition, there was no randomized controlled trial
(RCT) with evidence in the definition of causal relationship in our country. For this reason,
determining the factors affecting the early diagnosis behavior of women, planning and
implementing nursing interventions for these factors will contribute to the improvement of
early diagnosis behavior of women with cervical cancer. In this respect, health education for
cervical cancer and early diagnosis to be made to women in the risk group will have made a
unique contribution to RCT including motivational initiatives and home visits.
In order to evaluate the effectiveness of nursing interventions aimed at early detection of
cervical cancer, health beliefs and participation in scans in women aged 40-55 years at risk
for prognostic cervical cancer, One-way blind pre-test - final test was planned as RCT. In
this context, women in the risk group of 40-55 years of age with cervical cancer in the
project will constitute the universe of RCT. No pap smear test, no previous training for
cervical cancer, no previous hysterectomy, no previous cancer diagnosis, no current or past
sexual life and at least one of the identified risk factors Will have women involved. Women
who are in the risk group for cervical cancer and meet the inclusion and exclusion criteria
of the study will be randomly assigned to the experimental and control groups. In the
experimental group, cervical cancer will constitute nursing initiatives for health education,
home visits, problem-specific counseling and phone reminders for women at risk. Women in the
experimental group will receive a 15-week follow-up. Two reminders will be used to increase
motivation between home visits and trainings. The effectiveness of counseling and training
programs will be assessed by means of data collection tools that will be used for pretest /
posttest for women in the experimental and control groups and the data form prepared by the
researcher in the light of the literature.
Depending on the project, women are expected to participate in the cervical cancer screening
program. Home visits, trainings, counseling and reminders by phone will raise awareness
levels of women at risk for cervical cancer as a result. As a result, increased participation
of women in the risk group in screening programs will increase the probability of early
diagnosis and reduce cervical cancer mortality, reduce the cost and improve the health of the
community.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06223308 -
A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Terminated |
NCT03367871 -
Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer
|
Phase 2 | |
Active, not recruiting |
NCT04537156 -
Efficacy, Immunogenicity and Safty Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)
|
Phase 3 | |
Recruiting |
NCT03668639 -
Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT04242199 -
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
|
Phase 1 | |
Withdrawn |
NCT04806945 -
A Phase III Study to Evaluate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy in Patients With Advanced Cervical Cancer
|
Phase 3 | |
Active, not recruiting |
NCT04185389 -
Long-Term Follow-Up of HPV FOCAL Participants
|
||
Withdrawn |
NCT03007771 -
Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia
|
Phase 1 | |
Completed |
NCT03384511 -
The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies.
|
Phase 4 | |
Recruiting |
NCT05107674 -
A Study of NX-1607 in Adults With Advanced Malignancies
|
Phase 1 | |
Completed |
NCT05120167 -
Strategies for Endocervical Canal Investigation in Women With Abnormal Screening Cytology and Negative Colposcopy
|
N/A | |
Recruiting |
NCT05483491 -
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
|
Phase 1 | |
Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
Completed |
NCT05862844 -
Promise Women Project
|
N/A | |
Recruiting |
NCT04934982 -
Laparoscopic or Abdominal Radical Hysterectomy for Cervical Cancer(Stage IA1 With LVSI, IA2)
|
N/A | |
Recruiting |
NCT03876860 -
An Enhanced Vaginal Dilator to Reduce Radiation-Induced Vaginal Stenosis
|
N/A | |
Completed |
NCT03652077 -
A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies
|
Phase 1 | |
Completed |
NCT00543543 -
Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001)
|
Phase 3 | |
Terminated |
NCT04864782 -
QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer
|
Phase 2/Phase 3 | |
Recruiting |
NCT04226313 -
Self-sampling for Non-attenders to Cervical Cancer Screening
|
N/A |